nodes	percent_of_prediction	percent_of_DWPC	metapath
Fomepizole—CAT—Podofilox—Teniposide—lymphatic system cancer	0.0518	0.499	CbGdCrCtD
Fomepizole—CAT—Vinorelbine—Vincristine—lymphatic system cancer	0.0308	0.297	CbGdCrCtD
Fomepizole—Sinus bradycardia—Mitoxantrone—lymphatic system cancer	0.0273	0.0304	CcSEcCtD
Fomepizole—Transaminases increased—Carmustine—lymphatic system cancer	0.0237	0.0264	CcSEcCtD
Fomepizole—Phlebitis—Teniposide—lymphatic system cancer	0.0216	0.0241	CcSEcCtD
Fomepizole—CAT—Vinblastine—Vincristine—lymphatic system cancer	0.0212	0.204	CbGdCrCtD
Fomepizole—Taste metallic—Methotrexate—lymphatic system cancer	0.021	0.0234	CcSEcCtD
Fomepizole—Nystagmus—Vincristine—lymphatic system cancer	0.0192	0.0215	CcSEcCtD
Fomepizole—Anuria—Methotrexate—lymphatic system cancer	0.0191	0.0213	CcSEcCtD
Fomepizole—Phlebitis—Fludarabine—lymphatic system cancer	0.019	0.0211	CcSEcCtD
Fomepizole—Visual disturbance—Fludarabine—lymphatic system cancer	0.0172	0.0192	CcSEcCtD
Fomepizole—Phlebitis—Bleomycin—lymphatic system cancer	0.0139	0.0155	CcSEcCtD
Fomepizole—Vertigo—Mechlorethamine—lymphatic system cancer	0.0136	0.0152	CcSEcCtD
Fomepizole—Phlebitis—Carmustine—lymphatic system cancer	0.0121	0.0135	CcSEcCtD
Fomepizole—Flushing—Teniposide—lymphatic system cancer	0.0119	0.0133	CcSEcCtD
Fomepizole—Phlebitis—Mitoxantrone—lymphatic system cancer	0.0113	0.0126	CcSEcCtD
Fomepizole—Pharyngitis—Fludarabine—lymphatic system cancer	0.0112	0.0125	CcSEcCtD
Fomepizole—Visual impairment—Fludarabine—lymphatic system cancer	0.0109	0.0121	CcSEcCtD
Fomepizole—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.0108	0.012	CcSEcCtD
Fomepizole—Anaemia—Teniposide—lymphatic system cancer	0.0103	0.0115	CcSEcCtD
Fomepizole—Agitation—Teniposide—lymphatic system cancer	0.0103	0.0115	CcSEcCtD
Fomepizole—Anaemia—Fludarabine—lymphatic system cancer	0.00909	0.0101	CcSEcCtD
Fomepizole—Agitation—Fludarabine—lymphatic system cancer	0.00904	0.0101	CcSEcCtD
Fomepizole—Tachycardia—Teniposide—lymphatic system cancer	0.00891	0.00994	CcSEcCtD
Fomepizole—Hypotension—Teniposide—lymphatic system cancer	0.00853	0.00952	CcSEcCtD
Fomepizole—Convulsion—Fludarabine—lymphatic system cancer	0.00852	0.00951	CcSEcCtD
Fomepizole—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00847	0.00946	CcSEcCtD
Fomepizole—Decreased appetite—Teniposide—lymphatic system cancer	0.00794	0.00886	CcSEcCtD
Fomepizole—Vomiting—Mechlorethamine—lymphatic system cancer	0.00788	0.00879	CcSEcCtD
Fomepizole—Rash—Mechlorethamine—lymphatic system cancer	0.00781	0.00871	CcSEcCtD
Fomepizole—Dermatitis—Mechlorethamine—lymphatic system cancer	0.0078	0.00871	CcSEcCtD
Fomepizole—Flushing—Bleomycin—lymphatic system cancer	0.00769	0.00858	CcSEcCtD
Fomepizole—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00749	0.00835	CcSEcCtD
Fomepizole—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00747	0.00833	CcSEcCtD
Fomepizole—Nausea—Mechlorethamine—lymphatic system cancer	0.00736	0.00821	CcSEcCtD
Fomepizole—Body temperature increased—Teniposide—lymphatic system cancer	0.00722	0.00805	CcSEcCtD
Fomepizole—Abdominal pain—Teniposide—lymphatic system cancer	0.00722	0.00805	CcSEcCtD
Fomepizole—Dyspepsia—Fludarabine—lymphatic system cancer	0.00706	0.00788	CcSEcCtD
Fomepizole—Decreased appetite—Fludarabine—lymphatic system cancer	0.00698	0.00778	CcSEcCtD
Fomepizole—Visual impairment—Carmustine—lymphatic system cancer	0.00697	0.00777	CcSEcCtD
Fomepizole—Pain—Fludarabine—lymphatic system cancer	0.00686	0.00766	CcSEcCtD
Fomepizole—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00684	0.00763	CcSEcCtD
Fomepizole—Flushing—Carmustine—lymphatic system cancer	0.00671	0.00749	CcSEcCtD
Fomepizole—Pharyngitis—Mitoxantrone—lymphatic system cancer	0.00667	0.00744	CcSEcCtD
Fomepizole—Anaemia—Bleomycin—lymphatic system cancer	0.00666	0.00744	CcSEcCtD
Fomepizole—Body temperature increased—Fludarabine—lymphatic system cancer	0.00634	0.00708	CcSEcCtD
Fomepizole—Diarrhoea—Teniposide—lymphatic system cancer	0.00625	0.00697	CcSEcCtD
Fomepizole—Back pain—Carmustine—lymphatic system cancer	0.00609	0.00679	CcSEcCtD
Fomepizole—Vision blurred—Carmustine—lymphatic system cancer	0.00593	0.00662	CcSEcCtD
Fomepizole—Anaemia—Carmustine—lymphatic system cancer	0.00582	0.00649	CcSEcCtD
Fomepizole—Back pain—Vincristine—lymphatic system cancer	0.00581	0.00648	CcSEcCtD
Fomepizole—Vomiting—Teniposide—lymphatic system cancer	0.00581	0.00648	CcSEcCtD
Fomepizole—Agitation—Carmustine—lymphatic system cancer	0.00578	0.00645	CcSEcCtD
Fomepizole—Rash—Teniposide—lymphatic system cancer	0.00576	0.00642	CcSEcCtD
Fomepizole—Dermatitis—Teniposide—lymphatic system cancer	0.00575	0.00642	CcSEcCtD
Fomepizole—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00573	0.00639	CcSEcCtD
Fomepizole—Headache—Teniposide—lymphatic system cancer	0.00572	0.00638	CcSEcCtD
Fomepizole—Back pain—Mitoxantrone—lymphatic system cancer	0.00566	0.00631	CcSEcCtD
Fomepizole—Anaemia—Vincristine—lymphatic system cancer	0.00555	0.0062	CcSEcCtD
Fomepizole—Agitation—Vincristine—lymphatic system cancer	0.00552	0.00616	CcSEcCtD
Fomepizole—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00551	0.00615	CcSEcCtD
Fomepizole—Hypotension—Bleomycin—lymphatic system cancer	0.0055	0.00613	CcSEcCtD
Fomepizole—Diarrhoea—Fludarabine—lymphatic system cancer	0.00549	0.00613	CcSEcCtD
Fomepizole—Convulsion—Carmustine—lymphatic system cancer	0.00545	0.00608	CcSEcCtD
Fomepizole—Nausea—Teniposide—lymphatic system cancer	0.00542	0.00605	CcSEcCtD
Fomepizole—Anaemia—Mitoxantrone—lymphatic system cancer	0.00541	0.00603	CcSEcCtD
Fomepizole—Vertigo—Vincristine—lymphatic system cancer	0.0054	0.00602	CcSEcCtD
Fomepizole—Anxiety—Carmustine—lymphatic system cancer	0.00534	0.00596	CcSEcCtD
Fomepizole—Convulsion—Vincristine—lymphatic system cancer	0.00521	0.00581	CcSEcCtD
Fomepizole—Decreased appetite—Bleomycin—lymphatic system cancer	0.00512	0.00571	CcSEcCtD
Fomepizole—Visual disturbance—Methotrexate—lymphatic system cancer	0.00511	0.0057	CcSEcCtD
Fomepizole—Vomiting—Fludarabine—lymphatic system cancer	0.0051	0.00569	CcSEcCtD
Fomepizole—Convulsion—Mitoxantrone—lymphatic system cancer	0.00507	0.00566	CcSEcCtD
Fomepizole—Rash—Fludarabine—lymphatic system cancer	0.00506	0.00565	CcSEcCtD
Fomepizole—Dermatitis—Fludarabine—lymphatic system cancer	0.00506	0.00564	CcSEcCtD
Fomepizole—Pain—Bleomycin—lymphatic system cancer	0.00503	0.00561	CcSEcCtD
Fomepizole—Headache—Fludarabine—lymphatic system cancer	0.00503	0.00561	CcSEcCtD
Fomepizole—Tachycardia—Carmustine—lymphatic system cancer	0.00501	0.00559	CcSEcCtD
Fomepizole—Anxiety—Mitoxantrone—lymphatic system cancer	0.00496	0.00554	CcSEcCtD
Fomepizole—Hypotension—Carmustine—lymphatic system cancer	0.0048	0.00536	CcSEcCtD
Fomepizole—Nausea—Fludarabine—lymphatic system cancer	0.00477	0.00532	CcSEcCtD
Fomepizole—Shock—Mitoxantrone—lymphatic system cancer	0.0047	0.00524	CcSEcCtD
Fomepizole—Tachycardia—Mitoxantrone—lymphatic system cancer	0.00466	0.0052	CcSEcCtD
Fomepizole—Body temperature increased—Bleomycin—lymphatic system cancer	0.00465	0.00519	CcSEcCtD
Fomepizole—Hypotension—Vincristine—lymphatic system cancer	0.00458	0.00511	CcSEcCtD
Fomepizole—Somnolence—Carmustine—lymphatic system cancer	0.00457	0.00509	CcSEcCtD
Fomepizole—Decreased appetite—Carmustine—lymphatic system cancer	0.00446	0.00498	CcSEcCtD
Fomepizole—Hypotension—Mitoxantrone—lymphatic system cancer	0.00446	0.00498	CcSEcCtD
Fomepizole—Pain—Carmustine—lymphatic system cancer	0.00439	0.0049	CcSEcCtD
Fomepizole—Decreased appetite—Vincristine—lymphatic system cancer	0.00426	0.00476	CcSEcCtD
Fomepizole—Somnolence—Mitoxantrone—lymphatic system cancer	0.00424	0.00474	CcSEcCtD
Fomepizole—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0042	0.00469	CcSEcCtD
Fomepizole—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0042	0.00469	CcSEcCtD
Fomepizole—Pain—Vincristine—lymphatic system cancer	0.00419	0.00468	CcSEcCtD
Fomepizole—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00415	0.00463	CcSEcCtD
Fomepizole—Eosinophilia—Methotrexate—lymphatic system cancer	0.00414	0.00462	CcSEcCtD
Fomepizole—Pain—Mitoxantrone—lymphatic system cancer	0.00408	0.00456	CcSEcCtD
Fomepizole—Abdominal pain—Carmustine—lymphatic system cancer	0.00406	0.00453	CcSEcCtD
Fomepizole—Body temperature increased—Carmustine—lymphatic system cancer	0.00406	0.00453	CcSEcCtD
Fomepizole—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00401	0.00447	CcSEcCtD
Fomepizole—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0039	0.00436	CcSEcCtD
Fomepizole—Abdominal pain—Vincristine—lymphatic system cancer	0.00388	0.00432	CcSEcCtD
Fomepizole—Body temperature increased—Vincristine—lymphatic system cancer	0.00388	0.00432	CcSEcCtD
Fomepizole—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00377	0.00421	CcSEcCtD
Fomepizole—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00377	0.00421	CcSEcCtD
Fomepizole—Vomiting—Bleomycin—lymphatic system cancer	0.00374	0.00417	CcSEcCtD
Fomepizole—Drowsiness—Methotrexate—lymphatic system cancer	0.00373	0.00416	CcSEcCtD
Fomepizole—Rash—Bleomycin—lymphatic system cancer	0.00371	0.00414	CcSEcCtD
Fomepizole—Dermatitis—Bleomycin—lymphatic system cancer	0.00371	0.00414	CcSEcCtD
Fomepizole—Diarrhoea—Carmustine—lymphatic system cancer	0.00351	0.00392	CcSEcCtD
Fomepizole—Nausea—Bleomycin—lymphatic system cancer	0.0035	0.0039	CcSEcCtD
Fomepizole—Dizziness—Carmustine—lymphatic system cancer	0.0034	0.00379	CcSEcCtD
Fomepizole—Diarrhoea—Vincristine—lymphatic system cancer	0.00335	0.00374	CcSEcCtD
Fomepizole—Pharyngitis—Methotrexate—lymphatic system cancer	0.00332	0.00371	CcSEcCtD
Fomepizole—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00327	0.00365	CcSEcCtD
Fomepizole—Vomiting—Carmustine—lymphatic system cancer	0.00327	0.00364	CcSEcCtD
Fomepizole—Dizziness—Vincristine—lymphatic system cancer	0.00324	0.00362	CcSEcCtD
Fomepizole—Rash—Carmustine—lymphatic system cancer	0.00324	0.00361	CcSEcCtD
Fomepizole—Dermatitis—Carmustine—lymphatic system cancer	0.00324	0.00361	CcSEcCtD
Fomepizole—Visual impairment—Methotrexate—lymphatic system cancer	0.00323	0.0036	CcSEcCtD
Fomepizole—Headache—Carmustine—lymphatic system cancer	0.00322	0.00359	CcSEcCtD
Fomepizole—Vomiting—Vincristine—lymphatic system cancer	0.00312	0.00348	CcSEcCtD
Fomepizole—Rash—Vincristine—lymphatic system cancer	0.00309	0.00345	CcSEcCtD
Fomepizole—Dermatitis—Vincristine—lymphatic system cancer	0.00309	0.00345	CcSEcCtD
Fomepizole—Headache—Vincristine—lymphatic system cancer	0.00307	0.00343	CcSEcCtD
Fomepizole—Nausea—Carmustine—lymphatic system cancer	0.00305	0.0034	CcSEcCtD
Fomepizole—Vomiting—Mitoxantrone—lymphatic system cancer	0.00304	0.00339	CcSEcCtD
Fomepizole—Rash—Mitoxantrone—lymphatic system cancer	0.00301	0.00336	CcSEcCtD
Fomepizole—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00301	0.00336	CcSEcCtD
Fomepizole—Headache—Mitoxantrone—lymphatic system cancer	0.00299	0.00334	CcSEcCtD
Fomepizole—Nausea—Vincristine—lymphatic system cancer	0.00291	0.00325	CcSEcCtD
Fomepizole—Dysgeusia—Methotrexate—lymphatic system cancer	0.00285	0.00319	CcSEcCtD
Fomepizole—Nausea—Mitoxantrone—lymphatic system cancer	0.00284	0.00316	CcSEcCtD
Fomepizole—Back pain—Methotrexate—lymphatic system cancer	0.00282	0.00315	CcSEcCtD
Fomepizole—Vision blurred—Methotrexate—lymphatic system cancer	0.00275	0.00307	CcSEcCtD
Fomepizole—Anaemia—Methotrexate—lymphatic system cancer	0.00269	0.00301	CcSEcCtD
Fomepizole—Vertigo—Methotrexate—lymphatic system cancer	0.00262	0.00292	CcSEcCtD
Fomepizole—Convulsion—Methotrexate—lymphatic system cancer	0.00253	0.00282	CcSEcCtD
Fomepizole—Hypotension—Methotrexate—lymphatic system cancer	0.00222	0.00248	CcSEcCtD
Fomepizole—Somnolence—Methotrexate—lymphatic system cancer	0.00211	0.00236	CcSEcCtD
Fomepizole—Dyspepsia—Methotrexate—lymphatic system cancer	0.00209	0.00234	CcSEcCtD
Fomepizole—Decreased appetite—Methotrexate—lymphatic system cancer	0.00207	0.00231	CcSEcCtD
Fomepizole—Pain—Methotrexate—lymphatic system cancer	0.00203	0.00227	CcSEcCtD
Fomepizole—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00195	0.00217	CcSEcCtD
Fomepizole—Abdominal pain—Methotrexate—lymphatic system cancer	0.00188	0.0021	CcSEcCtD
Fomepizole—Body temperature increased—Methotrexate—lymphatic system cancer	0.00188	0.0021	CcSEcCtD
Fomepizole—Diarrhoea—Methotrexate—lymphatic system cancer	0.00163	0.00182	CcSEcCtD
Fomepizole—Dizziness—Methotrexate—lymphatic system cancer	0.00157	0.00176	CcSEcCtD
Fomepizole—Vomiting—Methotrexate—lymphatic system cancer	0.00151	0.00169	CcSEcCtD
Fomepizole—Rash—Methotrexate—lymphatic system cancer	0.0015	0.00167	CcSEcCtD
Fomepizole—Dermatitis—Methotrexate—lymphatic system cancer	0.0015	0.00167	CcSEcCtD
Fomepizole—Headache—Methotrexate—lymphatic system cancer	0.00149	0.00166	CcSEcCtD
Fomepizole—Nausea—Methotrexate—lymphatic system cancer	0.00141	0.00158	CcSEcCtD
